Navigation Links
Optimizing pfuturbo DNA Polymerase Amplification Reactions with,,,Perfect Match PCR Enhancer


Improve PCR product yield and specificity for difficult amplifications

Optimizing pfuturbo DNA Polymerase Amplification Reactions with Perfect Match PCR Enhancer

Frances Bai Holly Hogrefe
Stratagene

Certain PCR amplification systems produce multiple product bands or products of the wrong size due to nonspecific priming events, template secondary structures, or suboptimal PCR conditions. Stratagenes Perfect Match PCR enhancer *, improves the yield and specificity of problematic PCR reactions carried out with Taq DNA polymerase. We investigated the effects of Perfect Match PCR enhancer on amplifications performed with pfuturbo DNA polymerase,**, a robust high-fidelity PCR enzyme recently developed by Stratagene. Using PfuTurbo polymerase, the addition of the enhancer substantially improved the yield and specificity of suboptimal PCR systems; furthermore, PCR product yields and target-length capability were higher than for Taq plus Perfect Match enhancer reactions.

Stratagene is committed to developing innovative, high-performance PCR enzymes and PCR-enhancing agents to maximize product yield, specificity, and fidelity. Stratagene recently introduced PfuTurbo DNA polymerase, a special formulation of cloned Pfu DNA polymerase and a novel thermostable PCR-enhancing factor*** (the Turbo additive) that dramatically improves PCR product yields without altering DNA replication fidelity.1 PfuTurbo DNA polymerase is ideally suited for amplifying genomic DNA targets up to 10 kb and cloned targets up to 15 kb with the greatest accuracy possible.1 PCR comparisons have shown that PfuTurbo DNA polymerase amplifies longer targetsin higher yieldthan Pfu DNA polymerase (alone), Taq DNA polymerase, and other commercially availa
'"/>

Source:


Page: All 1 2 3 4 5 6

Related biology technology :

1. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
2. Optimizing electroporation parameters
3. Optimizing Büchi® Rotary Evaporator Applications
4. Optimizing electroporation parameters
5. Optimizing Büchi® Rotary Evaporator Applications
6. Optimizing Bchi Rotary Evaporator Applications
7. Optimizing electroporation parameters
8. Optimizing electroporation parameters
9. Optimizing electroporation parameters
10. Optimizing electroporation parameters
11. Optimizing electroporation parameters

Post Your Comments:
(Date:11/6/2009).... 6 ,, 3Q09 Corpor...enza(TM) E.U. Marketing Authorization to Astellas ...commercial readiness activities Expanded manageme...eting; and Director, Commercial Operations Appoin...udit Committee chairman , Upcoming 2009 Mil...
(Date:11/6/2009)...6 Intarcia Therapeutics, Inc. deli...OS® continuous delivery of exenatide) program... Annual Diabetes Technology Meeting in San Francis...in/prnh/20050301/SFTU126LOGO ) ,, Continuous ...wers Plasma Glucose, HbA1c and Reduces Weight in a...
(Date:11/5/2009).... 5 GenVec, Inc. (Nasdaq...r the third quarter ended September 30, 2009. GenV...share) for the three months ended September 30, 20...er share) in the comparable quarter of 2008. For t...net loss was $14.1 million ($0.15 per share), comp...
(Date:11/5/2009)...ewswire-FirstCall/ -- Imagenetix, Inc. (OTC Bullet...cer, President and CEO of Imagenetix, will be pres...CRO Conference on Thursday, December 3rd, at 10:30...bout LD MICRO ,, LD MICRO is a by-invitation on...lued companies in the micro-cap space. Since 2002,...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2
...er Provides Extensive Experience In Molecular Diag...h, Inc., a company revolutionizing spine care thro...logies, announced today that Roberto A. Macina, Ph...he company,s new Vice President of Research and De...eth Ward, M.D., Chairman and Chief Scientific Offi...
... Netherlands, February 24 ,Amsterdam Molecular The...f,human gene therapy, today reported its results f...clinical trial in LPL deficiency causes a delay of...GlyberaTM which is now expected H2 2009, - Posi...orijn resigned for personal reasons, - Start of...
...Colo., Feb. 23 The National Academy of Sciences (...ebruary 18, 2009 finds deficiencies in the nation,...rms and new research. The report also calls for t...nes for quality control, proficiency testing, cert...aspects of forensic science. , , The report notes...
Other Biology Technology:Axial Biotech Appoints Dr. Roberto Macina to Vice President of Research and Development 2Amsterdam Molecular Therapeutics Reports Full Year Results 2008 2Amsterdam Molecular Therapeutics Reports Full Year Results 2008 3Strengthening Forensic Toxicology in the United States: The American Board of Forensic Toxicology Response to the National Academy of Sciences Recommendations 2
(Date:11/4/2009)... Lowly bacteria, it turns out, hold the power to h...around the world clean up toxic waste on test site... RDX, were invented back in World War II and have ...e high-energy compounds are often used to propel t... TNT. , But with increased knowledge of their ...
(Date:11/4/2009)...LEY, Calif., Oct. 19 Spectros, dev...ing and imaging devices which shed light on life-t...igned exclusive distribution deals for both its T-...arkets covered include Australia, New Zealand, Th...name, Italy, France, Spain, Portugal, Poland, Gree...
(Date:11/4/2009)...ss., Oct. 20 Aware, Inc.... technology and biometrics software, today reporte...eptember 30, 2009. ,, Michael Tzannes, Aware,...lier today, we announced an agreement to sell our ... new fabless semiconductor company being spun out ...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2Spectros Signs New International Distribution Deals 2Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Award Winning Medical Technology From Germany 5432 1Award Winning Medical Technology From Germany 5432 2Award Winning Medical Technology From Germany 5432 3MicroRNA Biomarkers Provide Reliable Diagnosis from Blood Samples 5428 1MicroRNA Biomarkers Provide Reliable Diagnosis from Blood Samples 5428 2U S Patent Issued for Champions Biotechnologys Lead Oncology Drug 5424 1U S Patent Issued for Champions Biotechnologys Lead Oncology Drug 5424 2U S Patent Issued for Champions Biotechnologys Lead Oncology Drug 5424 3
...inked to genetic mutations, stunted growth and dec...rramatta River, the main tributary of Sydney Harbo...nting evidence that toxic sediments and seaweeds i...eatures. , The new findings, published in the jou...enetic mutations among crustaceans ( Melita plumul...
...alcohol syndrome are slight but classic: facial ma...ll eye openings and a short nose. , Researchers w...gure out how much alcohol it takes during what poi...g problems. , They have good evidence that just a... weeks of fetal life, typically before a woman kno...
...chers at the UC Davis M.I.N.D. Institute and The C...rgest study to date describing the medical and psy...der in which males have two "X" and two "Y" chromo...dy, published in the June 15, 2008, issue of the ... offers treatment recommendations for men and boys...
Other Biology News:Heavy metal link to mutations, low growth and fertility among crustaceans in Sydney Harbor tributary 2Alcohol consumption can cause too much cell death, fetal abnormalities 2UC Davis researchers define characteristics, treatment options for XXYY syndrome 2UC Davis researchers define characteristics, treatment options for XXYY syndrome 3
... with HRP conjugated rabbit polyclonal detection a... coating antibody. • BUF040A contains rab...ding between the coating and detection antibodies....ewly conjugated antibodies, to reconstitute lyophi...
...el piece, we can identify it using MALDI-TOF/TOF m...duce a mixture of peptides. The molecular weights ..., and the amino acid sequences of the top 10 peaks...ALDI-TOF/TOF. The masses and sequences will be use...
OmniSlide Heated Wash Module from Thermo Scientific
Factor Xa Protease from QIAGEN
Biology Products: